Updated 5-year STELLAR results in distal or middle-third locally advanced rectal cancer: short-course radiotherapy then chemotherapy vs long-course chemoradiotherapy did not significantly improve DFS (62.0% vs 58.7%; HR 0.849), but OS was higher (78.1% vs 69.7%; HR 0.739).
RCT
Tang et al. Five-Year Outcomes of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy for Locally Advanced Rectal Cancer: Updated Results of the STELLAR Trial